Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Flechner

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 16, 2015
Effect of Ramipril on Urinary Protein Excretion in Maintenance Renal Transplant Patients Converted to SirolimusD A Mandelbrot, J Alberú, A Barama, et al.
Transplantation|January 12, 1999
Transplantation of pediatric en bloc cadaver kidneys into adult recipientsM G Hobart, C S Modlin, A Kapoor, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 3, 2013
The association of center performance evaluations and kidney transplant volume in the United StatesJ D Schold, L D Buccini, T R Srinivas, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 24, 2005
Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppressionS M Flechner, P J Friend, J Brockmann, et al.
Transplantation|January 12, 1999
A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipientsS M Flechner, R K Avery, R Fisher, et al.
Transplantation Proceedings|December 1, 1984
The antagonistic effect of rifampin upon cyclosporine bioavailabilityD Van Buren, C A Wideman, M Ried, et al.
Transplantation Proceedings|March 20, 1999
Acute rejection and the flow cytometry crossmatchK J O'Malley, D J Cook, L Roeske, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 17, 2013
Prominent impact of community risk factors on kidney transplant candidate processes and outcomesJ D Schold, E L G Heaphy, L D Buccini, et al.
Transplantation Proceedings|March 20, 1999
The development of chronic renal allograft rejection may be predicted early following transplantationK J O'Malley, D J Cook, S M Flechner, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 23, 2014
First-in-human study of the safety and efficacy of TOL101 induction to prevent kidney transplant rejectionS M Flechner, S Mulgoankar, L B Melton, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 16, 2015
Effect of Ramipril on Urinary Protein Excretion in Maintenance Renal Transplant Patients Converted to SirolimusD A Mandelbrot, J Alberú, A Barama, et al.
Transplantation|January 12, 1999
Transplantation of pediatric en bloc cadaver kidneys into adult recipientsM G Hobart, C S Modlin, A Kapoor, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 3, 2013
The association of center performance evaluations and kidney transplant volume in the United StatesJ D Schold, L D Buccini, T R Srinivas, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 24, 2005
Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppressionS M Flechner, P J Friend, J Brockmann, et al.
Transplantation|January 12, 1999
A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipientsS M Flechner, R K Avery, R Fisher, et al.
Transplantation Proceedings|December 1, 1984
The antagonistic effect of rifampin upon cyclosporine bioavailabilityD Van Buren, C A Wideman, M Ried, et al.
Transplantation Proceedings|March 20, 1999
Acute rejection and the flow cytometry crossmatchK J O'Malley, D J Cook, L Roeske, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 17, 2013
Prominent impact of community risk factors on kidney transplant candidate processes and outcomesJ D Schold, E L G Heaphy, L D Buccini, et al.
Transplantation Proceedings|March 20, 1999
The development of chronic renal allograft rejection may be predicted early following transplantationK J O'Malley, D J Cook, S M Flechner, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 23, 2014
First-in-human study of the safety and efficacy of TOL101 induction to prevent kidney transplant rejectionS M Flechner, S Mulgoankar, L B Melton, et al.
Pageof 12